Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

T3 Peptide,Tumstatin (69-88), human Peptide

T3 Peptide,Tumstatin (69-88), human US$853.11 Excluding tax and shipping fees In stock Description About T3 Peptide,Tumstatin (69-88), human T3 Peptide,Tumstatin (69-88), human (Uniprot: Q01955) is a peptide derived from anti-angiogenic fragment of the type IV

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

T3 Peptide,Tumstatin (69-88), human

US$853.11

Excluding tax and shipping fees

In stock

Description

About T3 Peptide,Tumstatin (69-88), human

T3 Peptide,Tumstatin (69-88), human (Uniprot: Q01955) is a peptide derived from anti-angiogenic fragment of the type IV collagen alpha3 chain for cancer-targeting research. The T3 Peptide,Tumstatin (69-88), human peptide, H-LQRFTTMPFLFCNVNDVCNF-OH (Disulfide bridge: Cys12-Cys18) from JPT is produced under strict quality control and quality management.

T3 Peptide,Tumstatin (69-88), human - Specifications

Peptide sequence: H-LQRFTTMPFLFCNVNDVCNF-OH (Disulfide bridge: Cys12-Cys18)

Amount: 0.5 mg

Purity: > 90% (HPLC/MS)

Counterion: TFA

Delivery Format: Freeze-dried in plastic vial

Application(s): Cancer research

Condition(s)/Topic(s): Cancer

Standard Delivery Time: approx. 3 weeks

Non-RGD Cancer Peptides from JPT

Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.

Benefits of JPT’s Non-RGD Cancer Peptides

Each peptide quality controlled and guaranteed for identity and purity

CoA and HPLC-MS data available

High batch-to-batch consistency

Synthesis protocols designed to avoid toxic contaminants and side products

Provision of freeze dried aliquots for enhanced stability

Proven track record for applications in clinical studies

References

References for T3 Peptide,Tumstatin (69-88), human

ReferencesRead References with Peptides made by JPT

Documentation

Documentation for T3 Peptide,Tumstatin (69-88), human

T3 Peptide-Tumstatin-69-88-human.pdf

Properties

Properties of T3 Peptide,Tumstatin (69-88), human

0.5 mg

Cancer biomarker research

Cancer peptides

Freeze-dried in plastic vial

Human

Tumstatin

>90% (HPLC-MS)

No

Further Information to T3 Peptide,Tumstatin (69-88), human

Values

H-LQRFTTMPFLFCNVNDVCNF-OH (Disulfide bridge: Cys12-Cys18)

20mer cyclized cancer peptide (C12-C18)

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01How long do T3 test results take?

Facilities and clinics may have their own labs on-site, or they might send the blood to an outside lab for testing, so timing for results can vary. The usual time to wait for T3 results is one to two business days.

Source: www.webmd.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →